Tofacitinib 5mg (Xeljanz)

Tofacitinib 5mg (Xeljanz)

Xeljanz 5mg contains Tofacitinib 5mg, an oral Janus kinase (JAK) inhibitor used to treat several inflammatory and immune mediated conditions. It works by blocking JAK signaling pathways involved in immune system activity and inflammation.

Tofacitinib is used in selected patients with moderately to severely active rheumatoid arthritis, active psoriatic arthritis, active ankylosing spondylitis, and moderately to severely active ulcerative colitis. The 5mg strength is also used in certain pediatric inflammatory conditions according to approved dosing.

Xeljanz 5mg should be taken exactly as directed by a qualified healthcare professional. Treatment requires appropriate screening and monitoring because tofacitinib can increase the risk of serious infections and other significant adverse effects.

You can explore additional immunology and inflammatory condition medications at Rxmeds.store.

What is Tofacitinib 5mg (Xeljanz) Used For?

Xeljanz is prescribed for selected inflammatory and immune mediated conditions.

Common Uses

• Moderately to severely active rheumatoid arthritis
• Active psoriatic arthritis
• Active ankylosing spondylitis
• Moderately to severely active ulcerative colitis
• Active psoriatic arthritis in eligible pediatric patients
• Polyarticular course juvenile idiopathic arthritis in eligible pediatric patients

For several adult indications, Xeljanz is used in patients who have had an inadequate response or intolerance to one or more TNF blockers.

How Tofacitinib 5mg Works

Tofacitinib reduces inflammatory signaling by inhibiting Janus kinase enzymes.

Mechanism of Action

• Inhibits JAK signaling pathways.
• Reduces signaling from several inflammatory cytokines.
• Modulates excessive immune system activity.
• Helps reduce inflammation associated with autoimmune conditions.
• Helps improve symptoms and disease activity in appropriate patients.

How to Use Tofacitinib 5mg

Proper administration helps maintain consistent treatment.

Directions for Use

• Take exactly as prescribed by your healthcare provider.
• Xeljanz tablets can generally be taken with or without food.
• Take the medication at approximately the same time each day.
• Swallow the tablet with water.
• Do not change the dose or stop treatment without medical advice.
• Follow all recommended blood tests and medical monitoring during treatment.

The appropriate dosing schedule can vary by condition and may require adjustment for kidney or liver impairment or certain drug interactions.

Benefits of Tofacitinib 5mg

Key Benefits

• Targets inflammatory JAK signaling pathways.
• Helps reduce excessive immune system activity.
• Can improve symptoms associated with several inflammatory diseases.
• Used in rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
• Provides a convenient oral treatment option.
• 5mg tablets allow individualized treatment according to the prescribed regimen.

Possible Side Effects

Common Side Effects

• Upper respiratory tract infections
• Nasopharyngitis
• Diarrhea
• Headache

These are among the commonly reported adverse reactions associated with Xeljanz.

Serious Side Effects

Tofacitinib carries important warnings concerning:

• Serious bacterial, fungal, viral, and opportunistic infections
• Tuberculosis
• Certain malignancies
• Major cardiovascular events
• Blood clots
• Gastrointestinal perforation
• Changes in blood cell counts, liver enzymes, and cholesterol levels

The current prescribing information includes a boxed warning for serious infections, mortality, malignancy, major adverse cardiovascular events, and thrombosis.

Seek immediate medical attention for severe infection symptoms, chest pain, sudden shortness of breath, swelling or pain in a limb, severe abdominal pain, or other serious or unusual symptoms.

Safety and Precautions

Before taking Xeljanz 5mg, consider the following precautions.

Important Considerations

• Screening for tuberculosis is recommended before and during treatment.
• Viral hepatitis screening may be recommended before treatment.
• Blood counts and other laboratory tests should be monitored as recommended.
• Inform your healthcare provider about any current or recent infections.
• Tell your doctor about all medicines, vitamins, and supplements you are taking because tofacitinib can interact with other medicines.
• Inform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.
• Live vaccines should generally be avoided during treatment.
• Dose adjustments may be required with kidney or liver impairment.

Lifestyle Tips During Treatment

Healthy habits can support overall treatment management.

Helpful Tips

• Follow your prescribed treatment schedule consistently.
• Attend regular medical and laboratory monitoring appointments.
• Maintain good hygiene to reduce exposure to infections.
• Stay physically active as appropriate for your condition.
• Maintain a balanced and nutritious diet.
• Report signs of infection or unusual symptoms promptly.

Final Thoughts

Xeljanz 5mg (Tofacitinib) is an oral JAK inhibitor used to manage several inflammatory and immune mediated conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. By inhibiting JAK signaling, it helps reduce inflammatory activity and improve disease control in appropriate patients. Because of its significant safety considerations, treatment should include appropriate screening and ongoing medical monitoring.

Medical Disclaimer

This information is provided for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.

Individual results may vary depending on medical history, underlying condition, other medications, and response to treatment. Seek immediate medical attention if you experience serious side effects or unusual symptoms.

Products available on Rxmeds.store should only be used according to healthcare guidance and recommended instructions.